From the authors' 650,000 compound collection, they have selected approximately 15,000 potential small-molecule protease inhibitors, which were subjected to high-throughput screening against caspase-3. The screening yielded a series of hits that belong to 11 different scaffolds. Based on the structure of one of the hits, a new class of the small-molecule inhibitors with a double electrophilic warhead, 8-sulfonyl-pyrrolo[3,4-c]quinoline-1,3-diones (SPQ), was synthesized and tested in follow-up mechanistic and antiapoptosis assays. Mechanistic analysis of a representative compound of this class, CD-001-0011, showed that the compound exhibited a high potency (IC50 =130 nM), was reversible though noncompetitive, and had a broad selectivity profile to other caspases belonging to groups I to III. The compound was effective in preventing staurosporine-induced apoptosis in a few cell lines and retinoic acid-induced apoptosis in zebrafish. © 2006 Society for Biomolecular Sciences.
CITATION STYLE
Okun, I., Malarchuk, S., Dubrovskaya, E., Khvat, A., Tkachenko, S., Kysil, V., … Ivachtchenko, A. (2006). Screening for caspase-3 inhibitors: A new class of potent small-molecule inhibitors of caspase-3. Journal of Biomolecular Screening, 11(3), 277–285. https://doi.org/10.1177/1087057105285048
Mendeley helps you to discover research relevant for your work.